<DOC>
	<DOCNO>NCT00350142</DOCNO>
	<brief_summary>This study assess efficacy treat locally advanced pancreatic cancer use Stereotactic Body Radiotherapy ( use Trilogy ) Gemcitabine</brief_summary>
	<brief_title>Trilogy Stereotactic Body Radiotherapy Pancreatic Cancer</brief_title>
	<detailed_description>In study , propose combine stereotactic body radiotherapy ( SBRT ) standard gemcitabine chemotherapy . We hypothesize early administration systemic chemotherapy may prolong interval distant progression improve overall survival patient . In study , treat pancreatic cancer patient locally advance disease 3 week gemcitabine , follow Trilogy ( TM ) SBRT additional gemcitabine . 30 patient accrue study Stanford University Medical Center , site participate research study . Treatment protocol require placement 3-5 gold ( 99.9 % pure ) fiducials target purpose . Four 7 day placement fiducials , patient undergo 4D pancreatic protocol CT scan upper abdomen . In addition , FDG PET scan require treatment planning purpose . This imaging set process radiosurgery , use modify linac base radiation treatment planning system ( EclipseTM ) . An SBRT treatment plan develop base tumor geometry location . All patient receive single fraction 25 Gy prescribe isodose line completely surround gross pancreatic tumor volume ( GTV ) define contrast CT . Following SBRT , patient monitor clinically radiographically .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Pancreatic tumor exceed 10 cm great axial dimension Histologically confirm malignancy pancreas Unresectable CT criterion exploratory laparotomy laparoscopy Patients metastatic disease may treat symptomatic primary tumor Performance status 0 , 1 , 2 No chemotherapy two week prior two week follow radiosurgery patient prior radiotherapy upper abdomen patient receive prior pancreatic cancer therapy child , pregnant , breastfeed woman , lab personnel exclude uncontrolled intercurrent illness concurrent malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stereotactic Body Radiotherapy ( SBRT )</keyword>
	<keyword>pancreas cancer</keyword>
	<keyword>locally advanced</keyword>
	<keyword>local control</keyword>
	<keyword>Gemcitabine</keyword>
</DOC>